| Revenue growth | Value |
|---|---|
| 3Y CAGR | +176% |
| Profit growth | Value |
|---|---|
| 3Y CAGR | +266% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
Neuland LaboratoriesNEULANDLAB | ₹19,836.00 +136.00 (0.69%) | 25,270.71 | 55.84 | 12.46 | ||
Caplin Point LaboratoriesCAPLIPOINT | ₹2,457.20 +74.70 (3.14%) | 18,101.05 | 26.7 | 5.37 | ||
PfizerPFIZER | ₹3,903.80 +47.80 (1.24%) | 17,619.28 | 20.5 | 4.02 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹6,479.50 +106.00 (1.66%) | 15,969.75 | 94.15 | 18.3 |